Craig Audet enters Arena as SVP
This article was originally published in Scrip
Arena Pharmaceuticals, a biopharmaceutical company focused on discovering, developing and commercialising oral drugs that target G protein-coupled receptors, has promoted Craig Audet to senior vice-president of operations and head of global regulatory affairs. Mr Audet joined Arena in April 2011 as vice-president of regulatory affairs. He previously served as vice-president and head of the US regulatory affairs and marketed products group at Sanofi.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.